Published in Cancer Weekly, August 11th, 2009
Beginning in September 2009, Dr. Horning will report to Hal Barron, M.D., executive vice president, Global Development, and chief medical officer in the U.S. In her role, Dr. Horning will be will be a member of the Development Senior Staff and will be responsible for leading the medical and scientific strategies for the global clinical development portfolio in oncology. Dr. Horning will also lead the Disease Biology Leadership Team (DBLT) for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.